A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

€6.82M EUR

Funder	European Commission
Recipient Organization	Hospices Civils de Lyon
Country	France
Start Date	May 01, 2023
End Date	Apr 30, 2028
Duration	1,826 days
Number of Grantees	10
Roles	Participant; Coordinator; Third Party
Data Source	European Commission
Grant ID	`101104469`

Grant Description

The standard medical-and-surgical treatment of ovarian carcinoma patients relies on a systemic chemotherapy (carboplatin-paclitaxel), a tumor debulking surgery meant to be complete (no post-operative residual lesion), and a subsequent maintenance treatment with modern targeted agents.

Recent studies identified a patient population (~14,000 patients / year in Europe), whose prognostic is poor (5-year-overall survival (OS)

All Grantees

Institut Gustave Roussy; Fundacio Privada Per A la Recerca I la Docencia Sant Joan de Deu; Lyon Ingenierie Projets; Centre Hospitalier Universitaire; Centre de Lutte Contre Le Cancer Leon Berard; Institut Claudius Regaud; Hospices Civils de Lyon; Arcagy Association; Parc Sanitari Sant Joan de Deu; Susannah Carroll